<DOC>
	<DOCNO>NCT02009618</DOCNO>
	<brief_summary>To evaluate efficacy Rifaximin therapy start prior completion advance examination procedure ( colonoscopy ) patient pre-diagnosed irritable bowel syndrome , implement clinical practice .</brief_summary>
	<brief_title>The Effects Rifaximin Therapy Irritable Bowel Syndrome</brief_title>
	<detailed_description>Irritable Bowel Syndrome ( IBS ) chronic relapse disorder unknown etiology characterize abdominal pain bowel habit change without organic pathology . Pathophysiology fully understand , bacterial overgrowth one reason . Because , use drug effective gut flora raise ; Rifaximin one . This study investigate effectiveness Rifaximin IBS . This randomized , double-blinded , control study begin 500 patient ( 144 remove incompliance ) . Patients without organic bowel pathology meet Rome-III criterion , age 19-50 yo enrol study . Patients know Rifaximin allergy , lactose intolerance , treat IBS whit last 1 month well alarm symptom ( melena , fever , weight loss , anemia , rectal bleeding ) exclude . After routine biochemistry , blood count , stool test , Rifaximin tablet give group 1200 mg. daily 3 divided dos , placebo tablet give another group dose 10 day . Improvement symptom score record 10.day , 3. 6.week . In addition descriptive statistical method ( meanÂ±SD ) , Student's-T Mann-Whitney U-tests use comparison quantitative data , chi-square McNemar test use comparison qualitative data . Significance accept p &lt; 0.05 .</detailed_description>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>Patients age 18 50 year without alarm symptom , examine Gastroenterology Clinic , without endoscopic assessment , due complaint Irritable Bowel Syndrome , prediagnosed Irritable Bowel Syndrome accord Rome III criterion , include study . 1. age 18 year , 2. allergic Rifaximin , 3. pregnant lactating , 4. documented disease gastrointestinal system ( gastric duodenal ulcer , gastric cancer , small intestine colon cancer , inflammatory bowel disease [ Crohn 's Ulcerative Colitis ] , gastroparesis , chronic intestinal ischemia , etc . ) , 5. ( describe ) document disease pancreas , biliary tract , liver ( pancreatitis , biliary colic pain associate gallstone , acute cholecystitis , choledochal stone , hepatitis , hepatobiliary cancer , etc . ) , 6. previously undergone major abdominal surgery , 7. systemic disease ( collagen tissue disorder , kidney dysfunction , systemic infection , etc . ) , 8. identify psychiatric disorder , and/or 9. consume alcohol excessively</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>IBS</keyword>
	<keyword>Rifaximin</keyword>
</DOC>